Multi-Center, Double-Blind, Placebo-Controlled, Monotherapy Study of Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease
The purpose of this study is to evaluate the efficacy of NKO™ softgels in reducing decline of global cognitive function as measured by the Neuropsychological Test Battery (NTB), in patients diagnosed with early stage Alzheimer's disease when compared to fish oil and a placebo after 24 weeks of treatment.
100 项与 NeuroBioPharm, Inc. 相关的临床结果
0 项与 NeuroBioPharm, Inc. 相关的专利(医药)
100 项与 NeuroBioPharm, Inc. 相关的药物交易
100 项与 NeuroBioPharm, Inc. 相关的转化医学